Impact of ILM Peeling in RRD/ I-Peel
Launched by BERNER AUGENKLINIK · Feb 22, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • primary rhegmatogenous retinal detachment
- • of legal age (18 years or older)
- • in case of bilateral retinal detachment, only the first-affected eye will be included
- Exclusion Criteria:
- • pre-existing functional and morphological changes to the macula, hindering visual recovery (amblyopia, trauma, macular degeneration)
- • advanced retinal detachment with PVR stage C2 or more
- • eyes pre-operated within six months prior to the development of RD
- • state after any vitreoretinal surgery
- • state after complicated cataract surgery, including aphakia and anterior chamber lens implantation
- • patients with increased risk profiles
- • myopia magna (≥7 diopters)
- • advanced diabetic retinopathy
- • any chronic ocular or systemic inflammatory disease
- • any other proliferative systemic disease or condition associated with impaired wound healing
About Berner Augenklinik
Berner Augenklinik is a leading ophthalmic clinic dedicated to advancing eye care through innovative clinical research and high-quality patient services. With a focus on providing comprehensive ophthalmic treatments, the clinic is committed to enhancing patient outcomes by conducting rigorous clinical trials that evaluate cutting-edge therapies and technologies. Their multidisciplinary team of experienced ophthalmologists and researchers collaborates to ensure the highest standards of clinical excellence, contributing valuable insights to the field of ophthalmology while prioritizing patient safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Bern, , Switzerland
Patients applied
Trial Officials
Justus G Garweg, Prof. Dr.
Principal Investigator
Berner Augenklinik
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials